Home / NATCOPHARM.NS : NSE

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does NATCOPHARM.NS make money? Does NATCOPHARM.NS have pricing power? What's the Earnings Whisper? Will NATCOPHARM.NS profit more as the business scales? What is NATCOPHARM.NS's management track record? Is NATCOPHARM.NS's current price justified?

NATCO Pharma Limited

₹785.05 -$103.15 (-11.61%)

NSE · 16 Oct 2026 10:00 UTC

Previous Close

₹784.95

Day Range

₹780.95₹788.5

Year Range

₹779₹1226.8

Market Cap

144.45B

AVG Volume

516.98K

Trailing/Forward PE

12.29/15.69

PEG ratio

-0.3

Dividend Yield

0.57%

Next Earnings Date

2026-11-17

Primary Exchange

National Stock Exchange of India

Revenue (INR) · A

NATCOPHARM.NS Revenue (INR) by year
Period	Revenue (INR)
2026	40.78B
2025	44.32B
2024	40.02B
2023	27.09B
2022	19.46B
2021	20.56B
2020	19.15B
2019	20.95B
2018	21.85B
2017	19.98B

Net Income (INR) · A

NATCOPHARM.NS Net Income (INR) by year
Period	Net Income (INR)
2026	14.19B
2025	18.85B
2024	13.88B
2023	7.15B
2022	1.7B
2021	4.41B
2020	4.61B
2019	6.44B
2018	6.96B
2017	4.86B

Operating Income (INR) · A

NATCOPHARM.NS Operating Income (INR) by year
Period	Operating Income (INR)
2026	12.3B
2025	30B
2024	25.96B
2023	14.92B
2022	6.93B
2021	9.31B
2020	8.77B
2019	10.79B
2018	12.26B
2017	9.7B

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (INR) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

No video analysis for this stock yet. Request one from our team.

AI Analysis

NATCO Pharma Limited

Video analysis: NATCOPHARM.NS

News: NATCOPHARM.NS

Similar companies